Nature Search

Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study

Francis Ayuk
Eva-Maria Wagner-Drouet
Nicolaus Kröger
ResearchOpen Access02 May 2024
Bone Marrow Transplantation

Volume: 59, P: 1092-1096
The CD46-Jagged1 interaction is critical for human T_H1 immunity

The complement receptor CD46 and the Notch-Jagged system are important for the differentiation of helper T cells. Kemper and colleagues demonstrate that Jagged1 is a physiological ligand for CD46 and is critical for the generation of T helper type 1 cells in humans.

Gaëlle Le Friec
Devon Sheppard
Claudia Kemper
Research21 Oct 2012
Nature Immunology

Volume: 13, P: 1213-1221
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

In the ongoing phase 1/2 BNT211-01 trial, CLDN6-specific chimeric antigen receptor (CAR)-T cells given with or without CARVac, a CAR-T cell-amplifying RNA vaccine, were well-tolerated and exhibited encouraging clinical activity in patients with relapsed or refractory CLDN6-positive solid tumors, with the highest response rate in patients with germ cell tumors.

Andreas Mackensen
John B.A.G. Haanen
Uğur Şahin
ResearchOpen Access23 Oct 2023
Nature Medicine

Volume: 29, P: 2844-2853
Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization

Christian S. Michel
Daniel Teschner
Markus P. Radsak
ResearchOpen Access27 Dec 2019
Scientific Reports

Volume: 9, P: 1-7
Chemical and behavioural characterization of the rabbit mammary pheromone

Benoist Schaal
Gérard Coureaud
Guy Perrier
Research03 Jul 2003
Nature

Volume: 424, P: 68-72
CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

Nina Worel
Jarl E. Mooyaart
Jürgen Kuball
Correspondence15 May 2025
Bone Marrow Transplantation

Volume: 60, P: 1184-1186
Integrated perspective on translating biophysical to economic impacts of climate change

Uncertainty in estimates of the economic impacts of climate change makes it difficult to evaluate the benefits of mitigation. This Perspective reviews methods for determining economic damages from biophysical impacts, highlights critical gaps and suggests priorities moving forward.

Franziska Piontek
Laurent Drouet
Massimo Tavoni
Reviews17 Jun 2021
Nature Climate Change

Volume: 11, P: 563-572
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients

Christina Rautenberg
Jan Moritz Middeke
Friedrich Stölzel
CorrespondenceOpen Access08 Apr 2025
Blood Cancer Journal

Volume: 15, P: 1-4
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis

Philipp Berning
Norbert Schmitz
Bertram Glass
ResearchOpen Access08 May 2023
Leukemia

Volume: 37, P: 1511-1520
Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Jürgen Finke
Claudia Schmoor
Olga Grishina
ResearchOpen Access18 Aug 2022
Bone Marrow Transplantation

Volume: 57, P: 1664-1670
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

Christina Rautenberg
Friedrich Stölzel
Jan Moritz Middeke
ResearchOpen Access04 Oct 2021
Blood Cancer Journal

Volume: 11, P: 1-8
Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight

Sonia Caccia
Chiara Suffritti
Marco Cicardi
ResearchOpen Access17 Jan 2018
Scientific Reports

Volume: 8, P: 1-14
Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation

Chrysanthi Tsamadou
Sowmya Gowdavally
Daniel Fuerst
ResearchOpen Access08 Jul 2022
Bone Marrow Transplantation

Volume: 57, P: 1539-1547
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT

Urban Novak
Jarl E. Mooyaart
Florent Malard
Correspondence27 Aug 2024
Bone Marrow Transplantation

Volume: 59, P: 1631-1634
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

D. McLornan
D. J. Eikema
I. Yakoub-Agha
Research28 Apr 2021
Bone Marrow Transplantation

Volume: 56, P: 2160-2172
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Raffaella Greco
Jorinde D. Hoogenboom
Christian Chabannon
Correspondence22 Feb 2023
Bone Marrow Transplantation

Volume: 58, P: 603-606
ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management

Chrystelle Colas
Léa Guerrini-Rousseau
Katharina Wimmer
ReviewsOpen Access17 Oct 2024
European Journal of Human Genetics

Volume: 32, P: 1526-1541
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

Christian Koenecke
Dirk-Jan Eikema
Ibrahim Yakoub-Agha
CorrespondenceOpen Access23 Jul 2022
Bone Marrow Transplantation

Volume: 57, P: 1607-1611

Search

Filter By:

Search

Quick links